Clinical trial demonstrates greater cardiovascular protection from intensive statin therapy in acute coronary syndrome patients, indicating benefits of aggressive LDL reduction.
Among patients who have recently had an acute coronary syndrome, an intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular events than does a standard regimen. These findings indicate that such patients benefit from early and continued lowering of LDL cholesterol to levels substantially below current target levels.
No takes yet. Share an insight, caveat, or question.
Cannon et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: